Home › Isis Pharmaceuticals begins ISIS-DMPK Rx Phase 1 study for treatment of Myotonic Dystrophy Type 1
 

Keywords :   


Isis Pharmaceuticals begins ISIS-DMPK Rx Phase 1 study for treatment of Myotonic Dystrophy Type 1

2014-06-10 09:16:58| Biotech - Topix.net

Isis Pharmaceuticals, Inc. announced today that it has initiated a Phase 1 study for ISIS-DMPKRx.

Tags: type study treatment phase

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.11
23.11 WEEZER / maladroit 12\"
23.11
23.11 6'1ML REV-S
23.11speak up storys
23.11190mm LS0713FL
23.11That's Moulton
23.11SEED
More »